Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neumora Therapeutics Q1 EPS $(0.42) Misses $(0.38) Estimate

Author: Benzinga Newsdesk | May 12, 2025 03:02pm
Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.38) by 10.53 percent. This is a 23.53 percent decrease over losses of $(0.34) per share from the same period last year.

Posted In: NMRA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist